Document Detail


Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere.
MedLine Citation:
PMID:  23135527     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: The aim was to develop a slow-release poly-lactic-co-glycolic acid (PLGA)-5-fluorouracil microsphere, study the pharmacokinetic characteristics as well as to evaluate the effectiveness and safety of this preparation on colorectal tumor in vivo. METHODS: The PLGA-5-fluorouracil microsphere was prepared based on a spray-drying method, and the drug loading of 5-fluorouracil (the percentage of 5-fluorouracil content in the whole microsphere), in vitro 5-fluorouracil release profile and pharmacokinetic characteristics were carried out through high-performance liquid chromatography. The inhibiting effect on tumor growth and safety was examined using in vivo subcutaneously (s.c.) inoculated colorectal tumor models of nude mice. RESULTS: The size of the microsphere was less than 100 μm, drug loading was 20 % and drug release time lasted as long as 30 days. Slow-release PLGA-5-fluorouracil microsphere had longer half-life time (t (1/2)), larger apparent volume of distribution (V ( d )) and smaller area under the curve (AUC) compared with 5-fluorouracil. PLGA-5-fluorouracil microsphere significantly restrained tumor growth and this effect correlated with decreased expression of vascular endothelial growth factor in tumor cells. Body weight measurement and blood analysis did not suggest significant adverse effects on the mice during the study. CONCLUSIONS: The slow-release PLGA-5-fluorouracil microsphere developed here was suitable for regional use; it has pharmacokinetic advantages and appears safe and effective in controlling the tumor growth. This preparation shows promise in reducing local recurrence of colorectal cancer after resection, but needs further investigation.
Authors:
Jingquan Li; Yongdong Pu; Shiliang Wang; Manzhi Ding; Dianliang Chen; Mudan Zhu
Related Documents :
20705017 - Combination bacteriolytic cancer therapy: attacking cancer from inside out.
12734097 - Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.
9128967 - Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report ...
8330297 - Tumor cell resistance to energy deprivation and hyperthermia can be determined by the a...
22052617 - Fluorescent micelles based on star amphiphilic copolymer with a porphyrin core for bioi...
23797727 - Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and ou...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Cancer chemotherapy and pharmacology     Volume:  -     ISSN:  1432-0843     ISO Abbreviation:  Cancer Chemother. Pharmacol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806519     Medline TA:  Cancer Chemother Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
General Surgery Department, The 309th Hospital of the PLA, No. A17, Heishanhu road, Haidian district, Beijing, 100091, China, jingquanli2012@163.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  EXPRESSION OF SIRT1 IN CHOROIDAL NEOVASCULAR MEMBRANES.
Next Document:  Effects of estrogen and opioid blockade on blood pressure reactivity to stress in postmenopausal wom...